ALT

ALT

USD

Altimmune Inc. Common Stock

$4.110+0.190 (4.847%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$3.920

最高价

$4.160

最低价

$3.775

成交量

2.59M

公司基本面

市值

428.8M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

2.84M

交易所

NGM

货币

USD

52周价格范围

最低价 $2.9当前价 $4.110最高价 $11.16

相关新闻

GlobeNewswire

Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026

查看更多
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Reuters

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Metsera has become the obesity drug market's hottest ticket.

查看更多
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
GlobeNewswire

Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,

查看更多
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025